Mike Bates, who was chief financial officer at Silicon Genetics through its sale to Agilent Technologies, has been named chief financial officer at St. Francis Medical Technologies of Alameda, Calif., a privately held company working on treatments for degenerative spinal disorders, the company said last week. Bates previously was at Penederm and Collagen Aesthetics.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.